Weekly View

ICER Weekly View 05-18-18

From the desk of Mitchell Stein   Good morning. Drinking water from a fire hose – that’s the only way to describe trying to follow drug industry news this week. The President’s speech and elaboration from Azar and Gottlieb, approval of Aimovig, Ebola, biohacking and much more. I’m trying to keep this newsletter streamlined, but […]

Read More

ICER Weekly View 05-11-18

From the desk of Mitchell Stein   Good morning. The President will talk about prescription drug prices today (Friday). Last night, there was an off-the-record briefing of reporters on what will be included in the speech. We’ll take a look at what we might expect in the Inside the Beltway section below. Before we get […]

Read More

ICER Weekly View 05-04-18

From the desk of Mitchell Stein   Good morning. First, my apologies for the delay in publishing this morning. Second, before we dive into the week’s news let me wish you a Happy Star Wars Day. May the fourth be with you. (May the 4th, may the force… get it?) With those important matters out […]

Read More

ICER Weekly View 04-27-18

From the desk of Mitchell Stein   Good morning. Lots to cover today (isn’t there always), but first a public service announcement: Tomorrow (Saturday 4/28) is a national prescription drug take-back day. I’ve highlighted these in the past, but tomorrow’s promises to get more attention than ever as Google prepares to feature it on its […]

Read More

ICER Weekly View 04-20-18

From the desk of Mitchell Stein   Good morning. A busy week, starting with breakthrough lung cancer news out of American Association of Cancer Researchers conference (see Weekly View in-depth for details), news of an upcoming Presidential speech on drug pricing (See Inside the Beltway), and continuing developments in a potential Shire buyout (Allergan was […]

Read More

ICER Weekly View 04-13-18

From the desk of Mitchell Stein   Good morning. I couldn’t decide how to lead off this morning… Do I write about today’s date? Do I write about how cold it still is? Do I pick out a favorite story to highlight? Since I can’t decide, let’s jump into the news. This week we’ll look […]

Read More

ICER Weekly View 04-06-18

From the desk of Mitchell Stein   Good morning. Before we get to the week’s news, let me tell you a story. Like many, I take a generic statin – my health insurer uses a PBM, and I order this maintenance drug through their mail order pharmacy. The cost of a 90 day supply recently […]

Read More

ICER Weekly View 03-30-18

From the desk of Mitchell Stein   Good morning. I can’t help but lead with last night’s news that Walmart and Humana are talking about working more closely together, up to and including a purchase by Walmart of Humana. While reports indicate talks are in preliminary stages, the news caused a flurry of speculation on Twitter […]

Read More

ICER Weekly View 03-23-18

From the desk of Mitchell Stein   Good morning. We have a budget. Early this morning the Senate voted to approve the Omnibus that the House had approved on Thursday (The President is expected to sign later today). From a health care perspective, the surprises are what’s not included in the bill (we’ll take a […]

Read More

ICER Weekly View 03-16-18

From the desk of Mitchell Stein   Good morning. Years from now when you look up the phrase “too much news” you’ll find this past week as the case study. True on the national front (cabinet shake-ups, special elections, student protests, the loss of one of the brightest among us), and true for ICER, whose […]

Read More

Sign-up to have the Weekly View delivered to your inbox every Friday morning.

SIGN UP